Cargando…

Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study

BACKGROUND: Nasointestinal tubes (NITs) have been increasingly used in patients with small bowel obstruction (SBO); However, severe adverse events (SAEs) of NITs might threaten the lives of patients. The indications of NITs need to be identified. This study was designed to explore the indications fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui, Zhang, Jun-rong, Chen, Shuai, Hou, Ping, Chen, Qing-feng, Weng, Zong-qi, Shang-guan, Xin-chang, Lin, Bing-qiang, Chen, Xian-qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264659/
https://www.ncbi.nlm.nih.gov/pubmed/35799135
http://dx.doi.org/10.1186/s12876-022-02405-8
_version_ 1784743009459372032
author Wang, Hui
Zhang, Jun-rong
Chen, Shuai
Hou, Ping
Chen, Qing-feng
Weng, Zong-qi
Shang-guan, Xin-chang
Lin, Bing-qiang
Chen, Xian-qiang
author_facet Wang, Hui
Zhang, Jun-rong
Chen, Shuai
Hou, Ping
Chen, Qing-feng
Weng, Zong-qi
Shang-guan, Xin-chang
Lin, Bing-qiang
Chen, Xian-qiang
author_sort Wang, Hui
collection PubMed
description BACKGROUND: Nasointestinal tubes (NITs) have been increasingly used in patients with small bowel obstruction (SBO); However, severe adverse events (SAEs) of NITs might threaten the lives of patients. The indications of NITs need to be identified. This study was designed to explore the indications for the insertion of NITs in patients with SBO and to suggest the optimal strategies for individuals based on the outcomes of SAEs. METHODS: After propensity score matching, 68 pairs were included (Success group and failure group). The occurrence of SAEs and the clinical parameters were compared between the SAE group and the non-SAE group. Independent risk factors were evaluated among the subgroups. A novel scoring system was established to detect the subgroups that would benefit from NITs insertion. RESULTS: Successful implementation of NITs could avoid hypochloremia (p = 0.010), SAEs (p = 0.001), pneumonia (p = 0.006). SAEs occurred in 13 of 136 (9.6%) patients who accepted NITs insertion treatment. Risk factors for SAEs included tumors (p = 0.002), reduced BMI (p = 0.048), reduced hemoglobin (p = 0.001), abnormal activated partial thromboplastin time (p = 0.015) and elevated white blood cells (p = 0.002). A novel risk scoring system consists of hemoglobin before NITs insertion (95% CI 0.685, 0.893) and bowel obstruction symptoms relieved after NITs insertion (95% CI 0.575, 0.900) had the highest area under curve for predicting the occurrence of SAEs. We divided the risk score system into 3 grades, with the increasing grades, the rates of SAEs surged from 1.3% (1/74) to (6/11) 54.5%. CONCLUSION: NITs successfully insertion could avoid SAEs occurrence in SBO conservative treatment. SBO patients without anemia and could be relieved after NITs insertion could be the potential benefit group for this therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02405-8.
format Online
Article
Text
id pubmed-9264659
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92646592022-07-09 Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study Wang, Hui Zhang, Jun-rong Chen, Shuai Hou, Ping Chen, Qing-feng Weng, Zong-qi Shang-guan, Xin-chang Lin, Bing-qiang Chen, Xian-qiang BMC Gastroenterol Research BACKGROUND: Nasointestinal tubes (NITs) have been increasingly used in patients with small bowel obstruction (SBO); However, severe adverse events (SAEs) of NITs might threaten the lives of patients. The indications of NITs need to be identified. This study was designed to explore the indications for the insertion of NITs in patients with SBO and to suggest the optimal strategies for individuals based on the outcomes of SAEs. METHODS: After propensity score matching, 68 pairs were included (Success group and failure group). The occurrence of SAEs and the clinical parameters were compared between the SAE group and the non-SAE group. Independent risk factors were evaluated among the subgroups. A novel scoring system was established to detect the subgroups that would benefit from NITs insertion. RESULTS: Successful implementation of NITs could avoid hypochloremia (p = 0.010), SAEs (p = 0.001), pneumonia (p = 0.006). SAEs occurred in 13 of 136 (9.6%) patients who accepted NITs insertion treatment. Risk factors for SAEs included tumors (p = 0.002), reduced BMI (p = 0.048), reduced hemoglobin (p = 0.001), abnormal activated partial thromboplastin time (p = 0.015) and elevated white blood cells (p = 0.002). A novel risk scoring system consists of hemoglobin before NITs insertion (95% CI 0.685, 0.893) and bowel obstruction symptoms relieved after NITs insertion (95% CI 0.575, 0.900) had the highest area under curve for predicting the occurrence of SAEs. We divided the risk score system into 3 grades, with the increasing grades, the rates of SAEs surged from 1.3% (1/74) to (6/11) 54.5%. CONCLUSION: NITs successfully insertion could avoid SAEs occurrence in SBO conservative treatment. SBO patients without anemia and could be relieved after NITs insertion could be the potential benefit group for this therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02405-8. BioMed Central 2022-07-07 /pmc/articles/PMC9264659/ /pubmed/35799135 http://dx.doi.org/10.1186/s12876-022-02405-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Hui
Zhang, Jun-rong
Chen, Shuai
Hou, Ping
Chen, Qing-feng
Weng, Zong-qi
Shang-guan, Xin-chang
Lin, Bing-qiang
Chen, Xian-qiang
Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title_full Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title_fullStr Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title_full_unstemmed Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title_short Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case–control study
title_sort who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? a matched case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264659/
https://www.ncbi.nlm.nih.gov/pubmed/35799135
http://dx.doi.org/10.1186/s12876-022-02405-8
work_keys_str_mv AT wanghui whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT zhangjunrong whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT chenshuai whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT houping whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT chenqingfeng whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT wengzongqi whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT shangguanxinchang whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT linbingqiang whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy
AT chenxianqiang whowouldavoidsevereadverseeventsfromnasointestinaltubeinsmallbowelobstructionamatchedcasecontrolstudy